Dr. Ronan T. Swords
Claim this profileOHSU Knight Cancer Institute
Studies Acute Myeloid Leukemia
Studies Childhood Cancer
10 reported clinical trials
27 drugs studied
Area of expertise
1Acute Myeloid Leukemia
FLT3 positive
MLLr positive
TP53 positive
2Childhood Cancer
FLT3 positive
MLLr positive
TP53 positive
Affiliated Hospitals
Clinical Trials Ronan T. Swords is currently running
Entrectinib + ASTX727
for Acute Myeloid Leukemia
This trial tests a combination of two medications for patients with a tough-to-treat type of leukemia. One drug stops cancer cells from growing, while the other helps make healthy blood cells and kills bad ones. The goal is to find the best dose and see if this combination is safe and effective.
Recruiting2 awards Phase 1
Venetoclax + Azacitidine
for Myelodysplastic Syndrome
This phase II trial studies the effect of venetoclax and azacitidine in treating patients with therapy related or secondary myelodysplastic syndrome. Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Chemotherapy drugs, such as azacitidine, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving venetoclax in combination with azacitidine may work better in treating patients with therapy related or secondary myelodysplastic syndrome.
Recruiting1 award Phase 2
More about Ronan T. Swords
Clinical Trial Related2 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Ronan T. Swords has experience with
- Cytarabine
- Gilteritinib
- Venetoclax
- Azacitidine
- SNDX-5613
- Cedazuridine
Breakdown of trials Ronan T. Swords has run
Acute Myeloid Leukemia
Childhood Cancer
Granulocytic Leukemia
Polycythemia Vera
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ronan T. Swords specialize in?
Ronan T. Swords focuses on Acute Myeloid Leukemia and Childhood Cancer. In particular, much of their work with Acute Myeloid Leukemia has involved FLT3 positive patients, or patients who are MLLr positive.
Is Ronan T. Swords currently recruiting for clinical trials?
Yes, Ronan T. Swords is currently recruiting for 6 clinical trials in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Ronan T. Swords has studied deeply?
Yes, Ronan T. Swords has studied treatments such as Cytarabine, Gilteritinib, Venetoclax.
What is the best way to schedule an appointment with Ronan T. Swords?
Apply for one of the trials that Ronan T. Swords is conducting.
What is the office address of Ronan T. Swords?
The office of Ronan T. Swords is located at: OHSU Knight Cancer Institute, Portland, Oregon 97239 United States. This is the address for their practice at the OHSU Knight Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.